Labcorp Holdings Inc. (LH): Free Cash Flow
$1.21B
Year ended 2025-12-31
$1.16B
Trailing 12 months to 2026-06-30
-7.6%
3-year compound annual growth
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.21B | +10.0% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $1.10B | +25.4% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $874.10M | -42.7% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $1.53B | -43.2% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $2.69B | n/c | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $1.75B | +67.9% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $1.04B | +12.8% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $925.60M | -21.9% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $1.19B | +29.1% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $918.20M | n/c | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $726.60M | +35.7% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $535.50M | -13.1% | 2016-03-01, From 2014-01-01 |
| 2013-12-31 | $616.50M | -7.7% | 2016-03-01, From 2013-01-01 |
| 2012-12-31 | $667.60M | -6.0% | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | $709.90M | -6.3% | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $757.50M | +1.3% | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | $747.70M | +19.8% | 2012-02-24, From 2009-01-01 |
| 2008-12-31 | $624.20M | +10.1% | 2011-03-07, From 2008-01-01 |
| 2007-12-31 | $567.10M | n/a | 2010-02-24, From 2007-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $1.21B | +10.0% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $1.36B | +49.5% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $88.30M | -62.8% |
| Natera, Inc. (NTRA) | 2025-12-31 | $109.11M | +57.6% |
| Guardant Health, Inc. (GH) | 2025-12-31 | -$233.07M | n/m |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $66.89M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $126.63M | +98.5% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $28.33M | -22.5% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$124.21M | n/m |
Compare LH, DGX, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗